SynthesisFrontiers in pharmacology2024
Predicting adverse drug event using machine learning based on electronic health records: a systematic review and meta-analysis.
Synthesis in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Machine learning methods for predicting adverse drug events: A systematic review.British journal of clinical pharmacology · 2026Pooled it
- Hyperkalemia risk with finerenone in diabetic kidney disease: a real-world analysis from the FINE-TURK cohort.Clinical kidney journal · 2026Article
- Development and validation of a machine learning-based clinical decision support tool for stratifying intravenous medication risk in hospitalized patients with heart failure.International journal of clinical pharmacy · 2026Article
- Explainable Machine Learning for Predicting Adverse Drug Events in Older Adults with Polypharmacy: A Single-Center Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Safety Monitoring of High-Risk Antibiotics Using Artificial Intelligence: A Narrative Review with Focus on Real-World Evidence.Life (Basel, Switzerland) · 2026Review
- PHO-Agents: A Large Language Model-Powered Multi-Agent System for Predicting Health Outcomes.medRxiv : the preprint server for health sciences · 2026Article
- Review
- Integrating Pharmacogenomics and Network Topology for Machine Learning Prediction of HLA-Associated Severe Cutaneous Adverse Drug Reactions.International journal of molecular sciences · 2026Article
- Augmenting Electronic Health Records for Adverse Event Detection.medRxiv : the preprint server for health sciences · 2026Article
- Artificial Intelligence in Selected Domains of Drug Discovery: A Critical Narrative Review.Drug design, development and therapy · 2026Review
- Recent advancements in the application of artificial intelligence-based approaches for screening, diagnosis, prognosis and treatment of cervical cancer.Oncology reviews · 2026Review
- Development and prospective validation of a machine learning model for risk stratification of drug-induced liver injury using real-world clinical data.Therapeutic advances in drug safety · 2026Article
- Artificial intelligence approaches to predicting treatment non-adherence in chronic diseases: a narrative review.Frontiers in digital health · 2026Review
- Development and external validation of a machine learning model for predicting drug-induced immune thrombocytopenia in a real-world hospital cohort.BMC medical informatics and decision making · 2025Article
- Applying Machine Learning Techniques to Predict Drug-Related Side Effect: A Policy Brief.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Adverse drug events (ADEs) pose a significant challenge in current clinical practice. Machine learning (ML) has been increasingly used to predict specific ADEs using electronic health record (EHR) data. This systematic review provides a comprehensive overview of the application of ML in predicting specific ADEs based on EHR data. Methods: A systematic search of PubMed, Web of Science, Embase, and IEEE Xplore was conducted to identify relevant articles published from the inception to 20 May 2024. Studies that developed ML models for predicting specific ADEs or ADEs associated with particular drugs were included using EHR data. Results: A total of 59 studies met the inclusion criteria, covering 15 drugs and 15 ADEs. In total, 38 machine learning algorithms were reported, with random forest (RF) being the most frequently used, followed by support vector machine (SVM), eXtreme gradient boosting (XGBoost), decision tree (DT), and light gradient boosting machine (LightGBM). The performance of the ML models was generally strong, with an average area under the curve (AUC) of 76.68% ± 10.73, accuracy of 76.00% ± 11.26, precision of 60.13% ± 24.81, sensitivity of 62.35% ± 20.19, specificity of 75.13% ± 16.60, and an F1 score of 52.60% ± 21.10. The combined sensitivity, specificity, diagnostic odds ratio (DOR), and AUC from the summary receiver operating characteristic (SROC) curve using a random effects model were 0.65 (95% CI: 0.65-0.66), 0.89 (95% CI: 0.89-0.90), 12.11 (95% CI: 8.17-17.95), and 0.8069, respectively. The risk factors associated with different drugs and ADEs varied. Discussion: Future research should focus on improving standardization, conducting multicenter studies that incorporate diverse data types, and evaluating the impact of artificial intelligence predictive models in real-world clinical settings. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024565842, identifier CRD42024565842.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.